JP2010532656A5 - - Google Patents

Download PDF

Info

Publication number
JP2010532656A5
JP2010532656A5 JP2009545705A JP2009545705A JP2010532656A5 JP 2010532656 A5 JP2010532656 A5 JP 2010532656A5 JP 2009545705 A JP2009545705 A JP 2009545705A JP 2009545705 A JP2009545705 A JP 2009545705A JP 2010532656 A5 JP2010532656 A5 JP 2010532656A5
Authority
JP
Japan
Prior art keywords
seq
fusion protein
nucleic acid
acid molecule
immunogenic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009545705A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010532656A (ja
Filing date
Publication date
Priority claimed from GB0700759A external-priority patent/GB0700759D0/en
Priority claimed from GB0709707A external-priority patent/GB0709707D0/en
Application filed filed Critical
Priority claimed from PCT/US2008/050879 external-priority patent/WO2008089074A2/en
Publication of JP2010532656A publication Critical patent/JP2010532656A/ja
Publication of JP2010532656A5 publication Critical patent/JP2010532656A5/ja
Pending legal-status Critical Current

Links

JP2009545705A 2007-01-15 2008-01-11 癌退縮抗原ny−eso−1およびlage−1を含む融合タンパク質 Pending JP2010532656A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0700759A GB0700759D0 (en) 2007-01-15 2007-01-15 Novel fusion protein
US91484807P 2007-04-30 2007-04-30
US91492507P 2007-04-30 2007-04-30
GB0709707A GB0709707D0 (en) 2007-05-21 2007-05-21 Novel fusion protein
PCT/US2008/050879 WO2008089074A2 (en) 2007-01-15 2008-01-11 Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1

Publications (2)

Publication Number Publication Date
JP2010532656A JP2010532656A (ja) 2010-10-14
JP2010532656A5 true JP2010532656A5 (enExample) 2011-02-24

Family

ID=41111108

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009545705A Pending JP2010532656A (ja) 2007-01-15 2008-01-11 癌退縮抗原ny−eso−1およびlage−1を含む融合タンパク質

Country Status (15)

Country Link
EP (1) EP2118128B1 (enExample)
JP (1) JP2010532656A (enExample)
KR (1) KR20090122426A (enExample)
BR (1) BRPI0806501A2 (enExample)
CA (1) CA2674458A1 (enExample)
DK (1) DK2118128T3 (enExample)
EA (1) EA016818B1 (enExample)
ES (1) ES2398492T3 (enExample)
HR (1) HRP20130022T1 (enExample)
MX (1) MX2009007572A (enExample)
PE (1) PE20081687A1 (enExample)
PL (1) PL2118128T3 (enExample)
SI (1) SI2118128T1 (enExample)
TW (1) TW200902049A (enExample)
WO (1) WO2008089074A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008308474A (ja) * 2007-06-18 2008-12-25 Nitto Denko Corp 抗原ペプチド製剤の調製方法
CA2755734A1 (en) 2009-03-17 2010-09-23 Gaetan Otto Improved detection of gene expression
GB0910046D0 (en) 2009-06-10 2009-07-22 Glaxosmithkline Biolog Sa Novel compositions
AU2012302778B2 (en) * 2011-08-31 2016-11-24 Mie University Vaccine preparation for cancer treatment
GB201116248D0 (en) 2011-09-20 2011-11-02 Glaxosmithkline Biolog Sa Liposome production using isopropanol
AU2014300503B2 (en) 2013-06-28 2018-11-22 Auckland Uniservices Limited Amino acid and peptide conjugates and conjugation process
WO2015050158A1 (ja) 2013-10-01 2015-04-09 国立大学法人三重大学 抗原提示を促進するエピトープ間配列を含むt細胞誘導ワクチン
RU2017126206A (ru) 2014-12-23 2019-01-25 Маргарет Анне БРИМБЛЕ Аминокислотные и пептидные конъюгаты и направления их использования
WO2017138557A1 (ja) 2016-02-08 2017-08-17 国立大学法人三重大学 免疫チェックポイント阻害剤抵抗性腫瘍に対するt細胞輸注療法の前処置薬
AU2017223267B2 (en) 2016-02-26 2021-07-22 Auckland Uniservices Limited Amino acid and peptide conjugates and conjugation process
EP3883600B1 (en) * 2018-11-23 2025-03-12 Strike Pharma AB Bi-specific conjugates

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06205672A (ja) * 1992-03-19 1994-07-26 Nippon Zeon Co Ltd 日本脳炎ウイルス及びb型肝炎ウイルスの表面抗原タンパク質の抗原部位を持つキメラタンパク質の製造法、およびそれに用いる組み換えバキュロウイルス
US6686147B1 (en) * 1998-07-15 2004-02-03 Ludwig Institute For Cancer Research Cancer associated antigens and uses therefor
ATE507295T1 (de) * 2000-03-30 2011-05-15 Dendreon Corp Zusammensetzungen und verfahren für eine auf dendritischen zellen basierende immuntherapie
US20030044813A1 (en) * 2001-03-30 2003-03-06 Old Lloyd J. Cancer-testis antigens
AU2004314347B2 (en) * 2003-12-24 2011-05-19 Aduro Biotech, Inc. Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof
GB0409940D0 (en) * 2004-05-04 2004-06-09 Glaxosmithkline Biolog Sa Vaccine
EA012037B1 (ru) * 2004-11-16 2009-06-30 Круселл Холланд Б.В. Поливалентные вакцины, содержащие рекомбинантные вирусные векторы
US20090186049A1 (en) * 2006-05-26 2009-07-23 Vincent Brichard Method of treating mage positive cancer
DK2114993T3 (da) * 2007-01-15 2012-10-22 Glaxosmithkline Biolog Sa Vaccine

Similar Documents

Publication Publication Date Title
JP2010532656A5 (enExample)
JP2006149406A5 (enExample)
JP2008529558A5 (enExample)
JP2009268467A5 (enExample)
JP2012095652A5 (enExample)
JP2006187292A5 (enExample)
JP2011500073A5 (enExample)
JP2008536483A5 (enExample)
JP2010011868A5 (enExample)
JP2006141398A5 (enExample)
JP2013507907A5 (enExample)
BRPI0417509A (pt) molécula de proteìna quimérica de núcleo de vìrus da hepatite b (hbc) recombinante, partìculas, vacina ou inóculo, ácido nucleico, molécula de ácido nucleico recombinante, e, célula hospedeira
JP2009515831A5 (enExample)
JP2015501840A5 (enExample)
JP2007175057A5 (enExample)
JP2012515557A5 (enExample)
JP2014507146A5 (enExample)
NZ601345A (en) Combination adjuvant formulation
JP2011530309A5 (enExample)
JP2012531205A5 (enExample)
WO2011146933A3 (en) Universal dengue virus sequences and methods of use
HRP20130022T1 (hr) Fuzijski proteini koji sadrže antigene ny-eso-1 i lage-1 za odbacivanje tumora
JP2015524422A5 (enExample)
JP2019506175A5 (enExample)
JP2012516140A5 (enExample)